Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover.
about
Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@ast
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@en
type
label
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@ast
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@en
prefLabel
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@ast
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@en
P2093
P2860
P1476
Goserelin, as an ovarian prote ...... ng term altered bone turnover.
@en
P2093
Douglas J A Adamson
Fatma Gossiel
Geraldine Thomas
Richard A Anderson
Robert E Coleman
Robert Leonard
P2860
P356
10.1016/J.JBO.2016.02.003
P577
2016-02-11T00:00:00Z